• Theravance's drug grips the bacterial membrane more tightly than vancomcyin, enabling it to kill faster.

    FORBES: On The Cover/Top Stories

  • Theravance shares soared almost 14 percent in premarket trading 45 minutes before the market opening.

    WSJ: Elan enters $1B royalty deal with Theravance

  • Leading the group were shares of Theravance (THRX), up about 15.8% and shares of Affymax (AFFY) up about 11.8% on the day.

    FORBES: Santarus

  • At Theravance, Merck alum Roy Vagelos lured former Merck chemist Burton Christensen, co-inventor of three antibiotics at Merck, to come out of retirement in 1998 to help create new antibiotics.

    FORBES: Germ Warfare

  • Among the largest underlying components of XBI, in trading today Onyx Pharmaceuticals, Inc. ( NASD: ONXX) is off about 0.1%, Pharmacyclics, Inc. ( NASD: PCYC) is off about 0.6%, and Theravance Inc ( NASD: THRX) is lower by about 0.8%.

    FORBES: SPDR S&P Biotech ETF Experiences Big Outflow

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定